Comprehensive Guide to Nerve Blocks, Anaesthetic Agents, and Toxicity Management

Anaesthetic Dosage and Calculations

  • Fundamentals of Solution Concentrations:

    • 1ml1\,ml of water weighs exactly 1g1\,g.
    • A 100%100\% solution is defined as 1g/ml1\,g/ml (which is equivalent to 1000mg/ml1000\,mg/ml).
    • A 10%10\% solution contains 100mg/ml100\,mg/ml.
    • A 1%1\% solution contains 10mg/ml10\,mg/ml.
    • A 0.5%0.5\% solution contains 5mg/ml5\,mg/ml.
  • Formula for Calculating Maximum Volume:

    • Max volume allowed (ml)=Maximum dose (mg)Concentration (%)×10mg/ml\text{Max volume allowed (ml)} = \frac{\text{Maximum dose (mg)}}{\text{Concentration (\%)} \times 10\,mg/ml}

Clinical Pearls and Additives

  • General Injection Tips:

    • Use small-gauge needles (specifically 25G25G or 27G27G) to minimize trauma.
    • Warm the anaesthetic solution to body temperature prior to the procedure to reduce the burning sensation/pain associated with injection.
  • Sodium Bicarbonate (NaHCO3NaHCO_3):

    • Preparation: Add 1ml1\,ml of 8.4%8.4\% sodium bicarbonate to 9ml9\,ml of 1%1\% Lignocaine.
    • Clinical Benefits:
      • Decreases pain perceived during injection.
      • Results in a shorter onset of action.
      • Increases the effectiveness of the local anaesthetic in acidic (e.g., infected) environments.
  • Adrenaline (Epinephrine):

    • Function: Increases the total duration of action and allows for a higher maximum dose by reducing systemic absorption through local vasoconstriction.
    • Caution: Use care when administering in extremities (fingers, toes, nose, penis), although current evidence suggests the risks of ischemia may be overstated.

Local Anaesthetic Agent Comparison

  • Lignocaine (0.51%0.5-1\%\text{)}:

    • Onset: Rapid (25min2-5\,min).
    • Duration: 12hrs1-2\,hrs (extends to 4hrs4\,hrs with adrenaline).
    • Maximum Dose (Plain): 4mg/kg4\,mg/kg up to a total of 300mg300\,mg.
    • Maximum Dose (with Adrenaline): 7mg/kg7\,mg/kg up to a total of 500mg500\,mg.
  • Bupivacaine (0.25%0.25\%\text{)}:

    • Onset: Slow (25min2-5\,min).
    • Duration: 4hrs4\,hrs (extends to 8hrs8\,hrs with adrenaline).
    • Maximum Dose (Plain): 2mg/kg2\,mg/kg up to a total of 175mg175\,mg.
    • Maximum Dose (with Adrenaline): 3mg/kg3\,mg/kg up to a total of 225mg225\,mg.
  • Ropivacaine (0.75%0.75\%\text{)}:

    • Onset: Medium (115min1-15\,min).
    • Duration: 23hrs2-3\,hrs (extends to 6hrs6\,hrs with adrenaline).
    • Maximum Dose: 3mg/kg3\,mg/kg.

Nerve Block Procedures

  • Digital Nerve Block (Transthecal Approach):

    • Technique: Insert the needle at the center of the palmar digital crease until bone is contacted. Withdraw slightly until the loss of resistance to injection is felt.
    • Agents: Use 1%1\% Lignocaine or 0.250.5%0.25-0.5\% Bupivacaine.
    • Restriction: Specifically avoid the use of adrenaline for finger blocks.
  • Median Nerve Block:

    • Positioning: Place the wrist in slight extension.
    • Technique: Insert the needle at the radial border of the palmaris longus muscle, just proximal to the proximal wrist crease. Advance until a "slight pop" is felt or until the needle is approximately 1cm1\,cm deep.
    • Volume: Use 35ml3-5\,ml of 1%1\% Lignocaine or 0.250.5%0.25-0.5\% Bupivacaine.
    • Note: Apply a subcutaneous wheal while withdrawing the needle to ensure coverage of the palmar branch.
  • Radial Nerve Block:

    • Main Injection: Inject 25ml2-5\,ml of 1%1\% Lignocaine just lateral to the radial artery (always aspirate first to ensure no intravascular injection).
    • Supplemental: Provide a 56ml5-6\,ml subcutaneous field block extending from the initial insertion site to the dorsal midline of the wrist.
  • Ulnar Nerve Block:

    • Approach: Target the nerve under the Flexor Carpi Ulnaris (FCU) at the proximal palmar crease.
    • Technique: Inject a 35ml3-5\,ml wheal of 1%1\% Lignocaine as the needle is withdrawn.
    • Branch Coverage: Block cutaneous branches with a 56ml5-6\,ml subcutaneous band extending from the lateral border of the FCU to the dorsal midline.
  • Tibial Nerve Block:

    • Technique: Insert needle 1cm1\,cm proximal to the medial malleolus, perpendicular to the skin. Aim just posterior to the Posterior Tibial artery at a depth of 0.51cm0.5-1\,cm.
    • If Paresthesia occurs: If a "needle wiggle" triggers paresthesia, aspirate and inject 35ml3-5\,ml of 1%1\% Lignocaine.
    • If no Paresthesia: Continue advancing to the tibia, withdraw 1mm1\,mm, aspirate, and inject 57ml5-7\,ml as the needle is withdrawn over a distance of 1cm1\,cm.
    • Alternative Landmark: If the Tibial Artery (TA) cannot be palpated, enter just anterior to the Achilles tendon.

Local Anaesthetic Systemic Toxicity (LAST)

  • Central Nervous System (CNS) Manifestations:

    • Typically occurs before Cardiovascular (CVS) effects, except in massive intravenous overdoses where cardiac arrest may be the presenting symptom.
    • Symptoms: Tongue paresthesia, metallic taste, lightheadedness, tinnitus (ringing in ears), visual disturbances, muscle twitching, anxiety, confusion, seizures, coma, and apnea.
  • Cardiovascular System (CVS) Manifestations:

    • Bupivacaine is noted as being particularly cardiotoxic due to its prolonged binding to myocardial tissue.
    • Effects: Myocardial depression, hypotension, bradycardia, supraventricular and ventricular arrhythmias.
  • Methemoglobinemia:

    • Associated with Lignocaine or Prilocaine.
    • Note: This is not dose-related.
    • Symptoms: Blue mucous membranes (cyanosis), progressing to CNS and CVS manifestations of hypoxia.
  • Differential Diagnosis (DDx):

    • Allergy/Anaphylaxis: Presenting with rash, angioedema, tachycardia, hypotension, wheeze, or stridor.
    • Vasovagal Response: Presenting with lightheadedness, visual/hearing disturbances, bradycardia, and hypotension.
    • Excess Catecholamines: Presenting with tachycardia, hypertension, anxiety, and tremors.

Management of Toxicity

  • Immediate Resuscitative Steps:

    1. Call for help.
    2. Move the patient immediately to the Resuscitation (Resus) area.
    3. Establish IV access, apply O2O_2, and place on monitors. Have an advanced airway ready; intubate if there are signs of cardiac toxicity.
    4. Encourage mild hyperventilation to decrease the seizure threshold; hyperventilate if the patient is intubated.
  • Specific Pharmacological Management:

    • Seizures: Usually self-limiting; treat with Midazolam.
    • Hypotension and Bradycardia: Administer fluids, Atropine, or an Adrenaline infusion.
    • ECG Changes: Administer Sodium Bicarbonate (NaHCO3NaHCO_3) boluses of 2mmol/kg2\,mmol/kg until stabilization.
    • Cardiac Arrest (Lipid Rescue):
      • Use 20%20\% Lipid Emulsion (Intralipid).
      • Stat Dose: 100ml100\,ml (or 11.5ml/kg1-1.5\,ml/kg) IV bolus; repeat 12×1-2\times.
      • Infusion: Follow with 0.25ml/kg/min0.25\,ml/kg/min until hemodynamic stability is restored.
    • Methemoglobinemia: Administer Methylene Blue to all symptomatic patients at a dose of 12mg/kg1-2\,mg/kg IV over 5min5\,min.
  • Investigations:

    • Blood Gas: To confirm the presence of methemoglobinemia.
    • ECGs: Look for signs of Na+Na^+ (Sodium) channel blockage, including:
      • Right axis deviation.
      • Prolonged PR interval.
      • Prolonged QRS duration.
      • Large terminal R wave in lead aVR.